Update on Emerging HIV Drug Resistance to Integrase Inhibitors - How Concerned Should We Be?

Presented By: Leonard Kingwara, MPH, PhD; Francois Venter, MD, FCP, PhD; Bilaal Wilson Matola, MD, MPH; & Obiageli Okafor, MD, DrPH, MPH, Moderator

Webinar: Panel Presentation: Update on Emerging HIV Drug Resistance to Integrase Inhibitors - How Concerned Should We Be? With Live Q&A

Webinar Abstract: Effective control of the spread of HIV depends on using the right antiretroviral drugs. In 2019, the World Health Organization recommended using the integrase inhibitor, dolutegravir (DTG), in first- and second-line ART regimes, including for pregnant women.1 This recommendation was based on evidence showing that DTG was more effective, easier to take, and had fewer side effects relative to other drugs. It was also found that DTG had a lower risk of developing drug resistance compared to other drugs. By 2021, 110 countries with limited resources had switched to using DTG, and around 22 million people were receiving DTG-based treatment.2 However, recent survey data on HIV drug resistance show concerning levels of DTG resistance. In this webinar, we will discuss the findings of these studies, particularly in African countries. We will also explore the implications of emerging resistance to DTG at both the public health and individual health levels. These experts in HIV drug resistance will share their insights on how we might effectively combat emerging resistance and preserve the efficacy of available antiretroviral therapies, based on the lessons learned.

Earn PACE Credits:
1. Make sure you’re a registered member of Labroots (https://www.labroots.com/)
2. Watch the webinar on YouTube or on the Labroots Website (https://www.labroots.com/ms/webinar/panel-presentation-update-emerging-hiv-drug-resistance-integrase-inhibitors-concerned-be-live-q-a)
3. Click Here to get your PACE credits (Expiration date – May 15, 2026): (https://www.labroots.com/credit/pace-credits/8811/cert) 

Labroots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc

Видео Update on Emerging HIV Drug Resistance to Integrase Inhibitors - How Concerned Should We Be? канала Labroots